TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
TVRD
60 hedge funds and large institutions have $112M invested in Tvardi Therapeutics, Inc. Common Stock in 2015 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 26 increasing their positions, 11 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
60
Holders Change
+4
Holders Change %
+7.14%
% of All Funds
1.6%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
8
Increased
26
Reduced
11
Closed
4
Calls
$3K
Puts
–
Net Calls
+$3K
Net Calls Change
+$3K
Top Buyers
1 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$3.53M |
2 |
Renaissance Technologies
New York
|
+$2.5M |
3 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$2.36M |
4 |
Millennium Management
New York
|
+$1.89M |
5 |
CPM
Chesapeake Partners Management
Baltimore,
Maryland
|
+$913K |
Top Sellers
1 |
DPA
Devon Park Associates
|
-$5.59M |
2 |
HP
Harbourvest Partners
Boston,
Massachusetts
|
-$672K |
3 |
Wellington Management Group
Boston,
Massachusetts
|
-$569K |
4 |
![]()
JPMorgan Chase & Co
New York
|
-$418K |
5 |
HLA
Hamilton Lane Advisors
Conshohocken,
Pennsylvania
|
-$201K |